The Marine Corps is rolling out the Bolt-M loitering munition to infantry squads in 2026, delivering more than 600 man-packable systems under a $23.9 million Anduril contract starting in February.
The treatment of patients with blood cancers has undergone a radical transformation over the last couple of decades, with survival rates for some leukaemias and lymphomas increasing greatly. Diseases ...
Corin Cesaric is a Flex Editor at CNET. She received her bachelor's degree in journalism from the University of Missouri-Columbia. Before joining CNET, she covered crime at People Magazine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results